Standard Storage for Clonazepam
Clonazepam tablets, including those manufactured by Aurobindo Pharma, require storage at controlled room temperature between 20°C to 25°C (68°F to 77°F), with excursions permitted to 15°C to 30°C (59°F to 86°F). Employees at Aurobindo would learn to keep them in tight, light-resistant containers to protect from moisture and light degradation.[1]
Why These Conditions Matter
Clonazepam, a benzodiazepine, degrades under heat, humidity, or light exposure, potentially reducing potency. Aurobindo employees handle bulk packaging and follow USP guidelines (e.g., <659> for containers) during manufacturing and distribution to ensure stability through the labeled shelf life, typically 24-36 months.[1][2]
Handling During Manufacturing at Aurobindo
Aurobindo facilities use climate-controlled environments (15-30°C, <60% RH) for API and tablet production. Employees train on avoiding direct sunlight, freezing, or high humidity, per cGMP protocols. Blister packs or HDPE bottles with desiccants are standard to maintain integrity post-production.[3]
What Happens if Improperly Stored
Exposure beyond limits can lead to discoloration, potency loss, or impurity formation (e.g., via hydrolysis). FDA stability data shows clonazepam retains >95% potency under proper conditions; mishandling triggers batch rejection.[2][4]
Employee Training Specifics
Aurobindo Pharma's SOPs, aligned with FDA/ICH Q1A guidelines, mandate annual training for warehouse and QC staff on temperature logging (e.g., via data loggers) and excursion protocols. Violations risk 483 observations, as seen in past Aurobindo inspections.[3][5]
[1]: DailyMed - Aurobindo Clonazepam Label
[2]: USP Monograph - Clonazepam Tablets
[3]: FDA Inspection Report - Aurobindo Pharma
[4]: ICH Q1A Stability Testing
[5]: DrugPatentWatch.com - Clonazepam Patents & Stability